Related Experiment Video
Updated: Aug 5, 2026

Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment
Published on: July 26, 2024
Role of Renal Biomarkers in Sarcopenia or Frailty in Patients With Liver Cirrhosis
Jung Hee Kim1, Jae Yoon Jeong2, Ju-Yeon Cho3,4
1Division of Gastroenterology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
Background:
Sarcopenia and frailty are risk factors for poor prognosis in patients with liver cirrhosis. This study investigated the role of renal biomarkers in sarcopenia or frailty in patients with cirrhosis.
Methods:
A total of 78 patients with liver cirrhosis and serum creatinine levels < 1.5 mg/dL were analysed for serum renal biomarkers (creatinine-to-cystatin C ratio, interleukin [IL]-18, kidney injury molecule [KIM]-1, and neutrophil gelatinase-associated lipocalin [NGAL]), sarcopenia, and liver frailty index. Sarcopenia was assessed using the skeletal muscle index of the third vertebra. We analysed the risk of sarcopenia or frailty based on various renal biomarkers of cirrhosis.
Results:
The mean age was 59.2 years and 67.9% were men. The Child-Pugh class B score was noted in 17.9%. Sarcopenia or frailty (pre-frail and frail) was observed in 43 patients (55.1%). No significant differences in serum IL-18 (P = 0.285), NGAL (P = 0.537), or KIM-1 (P = 0.482) levels were observed according to sarcopenia or frailty. However, the creatinine-to-cystatin C ratio was significantly lower in patients with sarcopenia or frailty than in those without sarcopenia or frailty (0.73 vs. 0.83, P = 0.002). Multivariable analysis indicated that the risk factors for sarcopenia or frailty were Child-Pugh class B (odds ratio [OR], 9.04; 95% confidence interval [CI], 1.06-76.85; P = 0.044) and creatinine-to-cystatin C ratio < 0.8 (OR, 4.03; 95% CI, 1.45-11.25; P = 0.008). Serum IL-18, NGAL, and KIM-1 levels were not associated with sarcopenia or frailty.
Conclusion:
A lower serum creatinine-to-cystatin C ratio was associated with an increased risk of sarcopenia or frailty in patients with cirrhosis and favourable renal function.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Serum Studies: Renal Function Tests
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate